Release Date: 03/07/23 09:16 Summary: Shareholder Letter - ACCEPT - the Ramelius Takeover Offer Price Sensitive: Yes Download Document 232.47KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%